DaBomb Protein Biotech Corp. (TPEX:6578)

Market Cap	1.13B -9.4%
Revenue (ttm)	309.34M -8.4%
Net Income	-69.34M
EPS	-0.96
Shares Out	71.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.40 (2.55%)
Ex-Dividend Date	Jul 8, 2025

Volume	68,356
Average Volume	114,127
Open	16.10
Previous Close	15.70
Day's Range	15.75 - 16.10
52-Week Range	15.50 - 25.95
Beta	0.46
RSI	18.16
Earnings Date	May 12, 2026

About DaBomb Protein Biotech

DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023. DaBomb Protein Biotech Corp. was incorporated in 2001 and is based in Tainan City, Taiwan.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2001
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6578